Journal of Physiology & Pathology in Korean Medicine (동의생리병리학회지)

The Physiological Society of Korean Medicine and The Society of Pathology in Korean Medicine (대한동의생리학회·한의병리학회)
권호 표지

Analysis of Biological Experiment on Immunoactivity of Sipjeondabo-tang

십전대보탕의 면역활성에 관한 기초 실험 연구 문헌 분석

  • Kim, Jung Hoon (Basic Herbal Medicine Research Group, Korea Institute of Oriental Medicine) ;
  • Shin, Hyeun Kyoo (Basic Herbal Medicine Research Group, Korea Institute of Oriental Medicine)
  • 김정훈 (한국한의학연구원 한약기초연구그룹) ;
  • 신현규 (한국한의학연구원 한약기초연구그룹)
  • Received : 2012.08.16
  • Accepted : 2012.10.15
  • Published : 2012.10.25
Download PDF
⟨ Previous Next ⟩

Abstract

To investigate scientific evidence for the use of a Korean Medicine (KM), the papers regarding Sipjeondabo-tang (Shiquandabu-tang) frequently used in Korean medical clinics and hospitals were collected and analyzed. The papers were classified as being from domestic or international journals and by the year of publication. The mechanisms of immuno-activity Sipjeondabo-tang (Shiquandabu-tang) were researched. Among 41 papers, 4 were published as Korean papers whereas 7 were as Chinese papers and 40 were as Japanese papers. Sipjeondabo-tang (Shiquandabu-tang) regulated the productions of Th1 cytokines such as interleukin-2 (IL-2) and interferon-${\gamma}$ (IFN-${\gamma}$), and Th2 cytokines such as IL-4, IL-5, IL-6, IL-12 improving the function of immune organ including bone marrow, spleen, liver, thymus and peyer's patch. It also modulated the releases of immunoglobulin-G (IgG) and IgM. Thus, Sipjeondabo-tang (Shiquandabu-tang) balanced the Th1/Th2 immune responses as well as T/B cell. The regulation of immunoactivity could be speculated as an objective and scientific evidence of Sipjeondabo-tang (Shiquandabu-tang).

Keywords

Acknowledgement

Supported by : 한국한의학연구원

References

  1. 한의과대학 방제학교수 공편저. 방제학. 서울, 영림사, p 294, 2003.
  2. 이종태. 한국인의 한약재 복용실태 조사 연구. 서울, 식품의약품안전청, 2006.
  3. 丸山博文.川村秀樹.武元則人.小松靖弘.油田正樹.細谷英吉. 十全大補湯の食細胞に及ぼす影響. 炎症 8(5):461-465, 1988.
  4. 洪鉄, 松本司, 清原寛章, 山田陽城. 腸管パイエル板細胞からの骨髓細胞增殖促進因子産生に及ぼす十全大補湯の影響. 和漢医藥學會大會要旨集 12: 126, 1995.
  5. 洪鉄, 松本司, 清原寛章, 山田陽城. 十全大補湯投与による腸管パイエル板細胞中の T 細胞の活性化. 和漢医藥學會大會要旨集 13: 70, 1996.
  6. 松本司, 櫻井真澄, 清原寛章, 林正彦, 深海明子, 小宮山寛機, 山田陽城. 十全大補湯の経囗投与によるマウス肝および肺における NKT 細胞の誘導. 和漢医藥學會大會要旨集 15: 46, 1998.
  7. 松本司, 清原寛章, 櫻井眞澄, 山田陽城. 腸管免疫系におけるサイトカイン産生能に及ぼす十全大補湯の影響. The general meeting of Medical and Pharmaceutical Society for Wakan-yaku 15: 100, 1998.
  8. 高渶權, 柳逢夏, 朴東源, 柳基遠. 十全大補湯이 $CD4^+$+ 및 $CD8^+$ T 細胞數에 미치는 影響. 대한한방종양학회지 4(1):111-129, 1998.
  9. Hong, T., Matsumoto, T., Kiyohara, H., Yamada, H. Enhanced production of hematopoietic growth factors through T cell activation in Peyer's patches by oral administration of Kampo (Japanese herbal) medicine, "Juzen-Taiho-To". Phytomedicine 5(4):353-360, 1998. https://doi.org/10.1016/S0944-7113(98)80017-2
  10. 松本司, 清原寛章, 櫻井真澄, 山田陽城. 十全大補湯の腸管免疫系への作用と作用物質に關する研究. 和漢医藥學會大會要旨集 16: 17, 1999.
  11. Matsumoto, T., Sakurai, M.H., Kiyohara, H., Yamada H. Orally administered decoction of Kampo (Japanese herbal) medicine, ''Juzen-Taiho-To'' modulates cytokine secretion and induces NKT cells in mouse liver. Immunopharmacology 46: 149-161, 2000. https://doi.org/10.1016/S0162-3109(99)00166-6
  12. Matsumoto, T., Yamada, H. Orally administered Kampo (Japanese herbal) medicine "Juzen-Taiho-To" modulates cytokine secretion in gut associated lymphoretiuclar tissues in mice. Phytomedicine 6(6):425-430, 2000. https://doi.org/10.1016/S0944-7113(00)80070-7
  13. Jin, G.B., Watanabe, K., Nakada, T., Santa, K., Kato, H., Matsumoto, T., Toriizuka, K., Hanawa, T. The effects of Saiko-keishi-to and Juzen-taiho-to on Th1-Th2 balance in different age mice. Journal of Traditional Medicine 19: 7-14, 2002.
  14. Chino, A., Sakurai, H., Choo, M.K., Koizumi, K., Shimada, Y., Terasawa, K., Saiki, I. Juzentaihoto, a Kampo medicine, enhances IL-12 production by modulating Toll-like receptor 4 signaling pathways in murine peritoneal exudate macrophages. Int Immunopharmacol 5: 871-882, 2005. https://doi.org/10.1016/j.intimp.2005.01.004
  15. Anjiki, N., Hoshino, R., Ohnishi, Y., Hioki, K., Irie, Y., Ishige, A., Watanabe, K. A kampo formula Juzen-taiho-to induces expression of metallothioneins in mice. Phytother Res 19: 915-917, 2005. https://doi.org/10.1002/ptr.1747
  16. 陈玉春, 高依卿, 王碧英. 十全大补汤免疫調節作用的實驗研究. 中國中医藥科技 12(3):158-159, 2005.
  17. Matsuda, T., Uzuki, M., Uchida, T., Nakamura, M., Tai, M., Shiraishi, N., Sazaki, N., Yakushiji, F., Tomiyama, J., Suzuki, S., Fujiki, K., Taniguchi, K. Induction of mononuclear cell infiltration into liver by Japanese herbal medicine. Drugs Exptl Clin Res 31(5/6):207-214, 2005.
  18. 宗形佳織, 高嶋清江, 富田修平, 山本雅浩, 石毛敦, 渡辺賢治. C57BL/6マウス大腸のtype1 インターフェロン産生における 十全大補湯の影響. 和漢医薬學會誌 24(Supplement): 92, 2007.
  19. 宗形佳織, 渡辺賢治. 漢方薬十全大補湯が大腸のIFN-alpha 産生に及ぼす影響. 消化と吸収 32(2):185-188, 2010.
  20. 이상인, 강효신. 십전대보탕의 투여방법이 빈혈된 가토의 RBC, Hemoglobin 및 Hematocrit치 변화에 미치는 영향. 대한한의학회지 14(1):55-64, 1977.
  21. 小松靖弘.武元則人.丸山博文.土屋博司.油田正樹.細谷英吉, 篠原精ー,.浜田ー. 十全大補湯の免疫応答に及ぼす影響. 炎症 6(4):405-408, 1986.
  22. 亀田幸明, 杉山清, 横田正實, 張思巨, 畢頴, 市尾義昌. 十全大補湯, 補中益気湯によるコルチゾンの副作用軽減作用. 和漢医藥學會大會要旨集 5 : 110, 1988.
  23. 飯島治, 藤井祐一, 小林勇二郞, 窪庭睛男, 村上智香, 須藤和彦, 油田正樹, 細谷英吉. Mitomycin C に対する十全大補湯のマウスにおける副作用軽減効果. 日本癌治療學 會誌 23(6):1277-1282, 1988.
  24. Satomi, N., Sakurai, A., Iimura, F., Haranaka, R., Haranaka, K. Japanese modified traditional Chinese medicines as preventive drugs of the side effects induced by tumor necrosis factor and lipopolysaccharide. Mol Biother 1(3):155-162, 1989.
  25. 武元則人,.川村秀樹,.丸山博文,.小松靖弘,.油田正樹,.細谷英吉. 十全大補湯の細胞性免疫に對する作用. 炎症 9(1):49-52, 1989.
  26. 山田陽城. 十全大補湯の免疫調節活性物質の化學性狀と活性. 癌と化學療法 16(4):1500-1505, 1989.
  27. 戎野庄一. 免疫抑制条件下のマウスにおける十全大補湯投与に伴う免疫能の変化について. Biotherapy 4: 112-116, 1990.
  28. 池原進, 川村秀樹, 小松靖弘, 山田陽城, 比舎弘子, 安水良知, 井上陽子, 油田正樹. 放射線, 抗癌剤(MMC)の造血抑制に對する十全大補湯の効果. 和漢医藥學會大會要旨集 8: 11-12, 1991.
  29. 李永宇, 柳道坤, 韓宗鉉, 康舜洙. 四君子湯, 四物湯, 十全大補湯 및 補中益氣湯이 cisplatin 投與로 誘發된 體重減少와 血液變化에 미치는 影響. 원광한의학 2(1):155-175, 1992.
  30. Kiyohara, H., Matsumoto, T., Komatsu, Y., Yamada, H. Protective effect of oral adminiatration of a pectic polysaccharide fraction from a kampo (Japanese herbal) medicine "Juzen-Taiho-To" on adverse effects of cis-diaminedichloroplatinum. Planta Med 61: 531-534, 1995. https://doi.org/10.1055/s-2006-959364
  31. Sugiyama, K., Ueda, H., Ichio, Y., Yokota, M. Improvement of cisplatin toxicity and lethality by Juzen-taiho-to in mice. Biol Pharm Bull 18(1):53-58, 1995. https://doi.org/10.1248/bpb.18.53
  32. Sugiyama, K., Ueda, H., Ichio, Y. Protective effect of Juzen-taiho-to against carboplatin-induced toxic side effect in mice. Biol Pharm Bull 18(4):544-548, 1995. https://doi.org/10.1248/bpb.18.544
  33. Kiyohara, H., Matsumoto, T., Takemoto, N., Kawamura, H., Komatsu, Y., Yamada, H. Effect of oral administration of a pectic polysaccharide fraction from a kampo (Japanese herbal) medicine "Juzen-Taiho-To" on antibody response of mice. Planta Med 61: 429-434, 1995. https://doi.org/10.1055/s-2006-958130
  34. 池原進. 十全大補湯およびその成分の造血能に及ぼす効果. 医學进展16: 213-218, 1996.
  35. 李愛麗, 小松靖弘, 小野裕, 中谷文治, 中島邦夫, 山口宣夫. がん化學療法剤によるマウス後天的免疫不全狀態の生藥別回復の特徴. 感染症學雑誌 70(7):717-726, 1996.
  36. 金大根, 殷載淳, 全薰, 宋正模. 十全大補湯이 抗癌劑를 投與한 생쥐의 胸線細胞에 미치는 影響. 대한본초학회지 13(2):129-135, 1998.
  37. Iijima, K., Sun, S., Cyong, J.C., Jyonouchi, H. Juzen-Taiho-To, a Japanese herbal medicine, modulates type 1 and 2 T cell responses in old Balb/c mice. Am J Chin Med 27(2):191-203, 1999. https://doi.org/10.1142/S0192415X99000239
  38. 廖建群, 钱锋, 馬增春, 張立. 中医補血方劑對受照射小鼠造血功能的影響. 生物技術通訊 11(3):214, 2000.
  39. 曹志然, 周文英, 陈淑蘭, 馬晓莉, 馮天鑄. 十全大補湯小鼠免疫功能影響的實驗研究. 中國中医基础医學雜志 6(1):34-35, 2000.
  40. 曹志然, 周文英, 陈淑蘭, 王怀颖. 十全大補湯小鼠溶血素水平及脾指數的影響. 中國 現代医學雜志 10(12):46-47, 2000.
  41. 張濤, 柳朝陽, 王建杰, 王小灵. 十全大補湯對60Co照射小鼠免疫功能的影響. 黑龍江医樂科學 26(5):60, 2003.
  42. 石娅萍, 祝彼得, 黄茜, 鄭軼峰, 趙菊花. 十全大補湯配方颗粒對骨髓抑制小鼠外周血及促紅細胞生成素的影響. 檢驗医學与臨床 6(15):1221-1223, 2009.
  43. 石娅萍, 黄茜, 鄭軼峰, 祝彼得, 郭巍. 十全大補配方颗粒對骨髓抑制小鼠骨髓细胞細胞周期和細胞凋亡的影響. 時珍國医國樂 22(6):1515-1516, 2011.
  44. Viallard, J.F., Pellegrin, J.L., Ranchin, V., Schaeverbeke, T., Dehais, J., Longy-Boursier, M., Ragnaud, J.M., Leng, B., Moreau, J.F. Th1 (IL-2, interferon-gamma (IFN-g)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 115: 189-195, 1999. https://doi.org/10.1046/j.1365-2249.1999.00766.x
  45. Rincon, M., Anguita, J., Nakamura, T., Fikrig, E., Flavell, R.A. Interleukin (IL)-6 directs the differentiation of IL-4- producing CD4+ T cells. J Exp Med 185(3):461-469, 1997. https://doi.org/10.1084/jem.185.3.461
  46. Yanagida, M., Fukamachi, H., Ohgami, K., Kuwaki, T., Ishii, H., Uzumaki, H., Amano, K., Tokiwa, T., Mitsui, H., Saito, H., Iikura, Y., Ishizaka, T., Nakahata, T. Effects of T-helper 2-type cytokines, interleukin-3 (IL-3), IL-4, IL-5, and IL-6 on the survival of cultured human mast cells. Blood 86(10):3705-3714, 1995.
  47. Drazen, J.M., Arm, J.P., Austen, K.F. Sorting out the cytokines of asthma. J Exp Med 183: 1-5, 1996. https://doi.org/10.1084/jem.183.1.1
  48. Inobe, J., Slavin, A.J., Komagata, Y., Chen, Y., Liu, L., Weiner, H.L. IL-4 is a differentiation factor for transforming growth factor- I secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis. Eur J Immunol 28: 2780-2790, 1998. https://doi.org/10.1002/(SICI)1521-4141(199809)28:09<2780::AID-IMMU2780>3.0.CO;2-J
  49. Humbert, M., Corrigan, C.J., Kimmitt, P., Till, S.J., Kay, A.B., Durham, S.R. Relationship between IL-4 and IL-5 mRNA Expression and Disease Severity in Atopic Asthma. Am J Respir Crit Care Med 156: 704-708, 1997. https://doi.org/10.1164/ajrccm.156.3.9610033
  50. Martinez, O.M., Gibbons, R.S., Garovoy, M.R., Aronson, F.R. IL-4 inhibits IL-2 receptor expression and IL-2-dependent proliferation of human T cells. The J Immunol 144(6):2211-2215, 1990.
  51. Ohnishi, T., Kita, H., Weiler, D., Sur, S., Sedgwick, J.B., Calhoun, W.J., Busse, W.W., Abrams, J.S., Gleich, G.J. IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction. Am J Respir Crit Care Med 147(4):901-907, 1993. https://doi.org/10.1164/ajrccm/147.4.901
  52. Manetti, R., Parronchi, P., Giudizi, M.G., Piccinni, M.P., Maggi, E., Trinchieri, G., Romagnani, S. Natural killer cell stimulatory factor (Interleukin 12 [IL-12]) induces T helper type 1 (Thl)-specific immune responses and inhibits the development of ID4-producing Th cells. J Exp Med 177: 1199-1204, 1993. https://doi.org/10.1084/jem.177.4.1199
  53. Wenner, C.A., Guler, M.L., Macatonia, S.E., O'Garra, A., Murphy, K.M. Roles of IFN-gamma and IFN-alpha in IL-12-induced T helper cell-1 development. J Immunol 156(4):1442-1447, 1996.
  54. Warren, H.S., Kinnear, B.F., Phillips, J.H., Lanier, L.L. Production of IL-5 by human NK cells and regulation of IL-5 secretion by IL-4, IL-10, and IL-12. J Immunol 154(10):5144-5152, 1995.
  55. Zang, X.X., Qian, B.C., Liu, J. Effects of immunoagents on circulating serum hemolysin formation in bone marrow and spleen. Zhongguo Yao Li Xue Bao 11(5):477-480, 1990.
  56. Inoue, T., Hirabayashi, Y., Mitsui, H., Sasaki, H., Cronkite, E.P., Bullis, J.E. Jr, Bond, V.P., Yoshida, K. Survival of spleen colony-forming units (CFU-S) of irradiated bone marrow cells in mice: evidence for the existence of a radioresistant subfraction. Exp Hematol 23(12):1296-1300, 1995.
  57. McLaren, J., Prentice, A., Charnock-Jones, D.S., Sharkey, A.M., Smith, S.K. Immunolocalization of the apoptosis regulating proteins Bcl-2 and Bax in human endometrium and isolated peritoneal fluid macrophages in endometriosis. J Hum Reprod 12(1):146-152, 1997. https://doi.org/10.1093/humrep/12.1.146
  58. Solano-Gallego, L., Riera, C., Roura, X., Iniest, L., Gallego, M., Valladares, J.E., Fisa, R., Castillejo, S., Alberola, J., Ferrer, L., Arboix, M., Port, M. Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas Evolution in the course of infection and after treatment. Vet Parasitol 96: 265-276, 2001. https://doi.org/10.1016/S0304-4017(00)00446-5
  59. Brown, W.C., Mcelwain, T.F., Palmer, G.H., Chantler, S.E., Estes, D.M. Bovine CD41 T-lymphocyte clones specific for rhoptry-associated protein 1 of Babesia bigemina stimulate enhanced immunoglobulin G1 (IgG1) and IgG2 synthesis. Infect Immun 67(1):155-164, 1999.
  60. Ehrenstein, M.R., O'keefe, T.L., Davies, S.L., Neuberger, M.S. Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. Proc Natl Acad Sci USA 95: 10089-10093, 1998. https://doi.org/10.1073/pnas.95.17.10089
  61. Shi, Y., Agematsu, K., Ochs, H.D., Sugane, K. Functional analysis of human memory B-cell subpopulations: IgD+CD27+ B cells are crucial in secondary immune response by producing high affinity IgM. Clin Immunol 108(2):128-137, 2003. https://doi.org/10.1016/S1521-6616(03)00092-5
  62. Campagne, M.V., Thibodeaux, H., van Bruggen, N., Cairns, B., Lowe, D.G. Increased binding activity at an antioxidant-responsive element in the metallothionein-1 promoter and rapid induction of metallothionein-1 and -2 in response to cerebral ischemia and reperfusion. J Neurosci 20(14):5200-5207, 2000.
  63. Miura, N., Koizumi, S. Gene expression profiles in the liver and kidney of metallothionein-null mice. Biochem Biophys Res Commun 332: 949-955, 2005. https://doi.org/10.1016/j.bbrc.2005.05.043
  64. Lazo, J.S., Kondo, Y., Dellapiazza, D., Michalska, A.E., Choo, K.H., Pitt, B.R. Enhanced sensitivity to oxidative stress in cultured embryonic cells from transgenic mice deficient in metallothionein I and II genes. J Biol Chem 270: 5506-5510, 1995. https://doi.org/10.1074/jbc.270.10.5506
  65. Bhatnagar, S., Shanks, N., Meaney, M.J. Plaque-forming cell responses and antibody titers following injection of sheep red blood cells in nonstressed, acute, and/or chronically stressed handled and nonhandled animals. Dev Psychobiol 29(2):171-181, 1996. https://doi.org/10.1002/(SICI)1098-2302(199603)29:2<171::AID-DEV6>3.0.CO;2-P
  66. van der Wal, A.C., Piek, J.J., de Boer, O.J., Koch, K.T., Teeling, P., van der Loos, C.M., Becker, A.E. Recent activation of the plaque immune response in coronary lesions underlying acute coronary syndromes. Heart 80: 14-18, 1998. https://doi.org/10.1136/hrt.80.1.14
  67. Chen, Z., Matsuo, K., Asanuma, H., Takahashi, H., Iwasaki, T., Suzuki, Y., Aizawa, C., Kurata, T., Tamura, S. Enhanced protection against a lethal in칤enza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs. Vaccine 17: 653-659, 1999. https://doi.org/10.1016/S0264-410X(98)00247-3
  68. Trzonkowski, P., Mysliwska, J., Szmit, E., Wieckiewicz, J., Lukaszuk, K., Brydak, L.B., Machaa, M., Mysliwski, A. Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination- an impact of immunosenescence. Vaccine 21: 3826-3836, 2003. https://doi.org/10.1016/S0264-410X(03)00309-8
  69. Bernkop-Schnuch, A., Krist, S., Vehabovic, M., Valenta, C. Synthesis and evaluation of lysozyme derivatives exhibiting an enhanced antimicrobial action. Eur J Pharm Sci 6: 301-306, 1998. https://doi.org/10.1016/S0928-0987(97)10026-4
  70. Akhtar, M., Hayat, C.S. Erythrocyte rosette formation assay for the detection of cell medicated immune response in buffaloes vaccinated against ticks. Pak J Biol Sci 1(4):383-385, 1998. https://doi.org/10.3923/pjbs.1998.383.385
  71. Tanaka, K., Hirai, H., Takano, S., Nakamura, M., Nagata, K. Effects of prostaglandin D2 on helper T cell functions. Biochem Biophys Res Commun 316: 1009-1014, 2004. https://doi.org/10.1016/j.bbrc.2004.02.151
  72. Xue, L., Gyles, S.L., Wettey, F.R., Gazi, L., Townsend, E., Hunter, M.G., Pettipher, R. Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells. J Immunol 175: 6531-6536, 2005. https://doi.org/10.4049/jimmunol.175.10.6531
  73. Sharples, E.J., Patel, N., Brown, P., Stewart, K., Mota-Philipe, H., Sheaff, M., Kieswich, J., Allen, D., Harwood, S., Raftery, M., Thiemermann, C., Yaqoob, M.M. Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol 15: 2115-2124, 2004. https://doi.org/10.1097/01.ASN.0000135059.67385.5D